This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novexel. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: David Alun Rowlands: Innovator in Antibacterial Medicaments
Introduction
David Alun Rowlands is a notable inventor based in Poissy, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial drugs. His innovative work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
David Alun Rowlands holds a patent for "Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments." This invention focuses on nitrogenated heterocyclic compounds, detailing their preparation and application as antibacterial drugs. The compounds are represented by a general formula (I), wherein R represents a (CH)n-NHR or (CH)n-NHR radical, where R is a (C-C) alkyl and n is equal to 1 or 2. This patent highlights his commitment to advancing medical science and improving health outcomes.
Career Highlights
Rowlands is associated with Novexel, a company known for its innovative approaches in the pharmaceutical industry. His work at Novexel has allowed him to explore and develop new medicinal compounds that can combat bacterial infections effectively. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Throughout his career, David has collaborated with talented individuals such as Maxime Lampilas and Adel Kebsi. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
David Alun Rowlands exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to antibacterial medicaments through his patented work demonstrate his commitment to improving healthcare. His ongoing efforts continue to inspire advancements in medicinal chemistry.